Table 1.
Participant Demographics and Baseline Characteristics
| Characteristic | CVC 150 mg (n = 24) |
|---|---|
| Demographics | |
| Age (years), mean (SD) | 43.3 (12.9) |
| Female, n (%) | 12 (50.0) |
| White, n (%) | 21 (87.5) |
| Hispanic or Latino, n (%) | 2 (8.3) |
| BMI (kg/m2), mean, (SD) | 25.2 (3.7) |
| IBD, n (%) | |
| Ulcerative colitis | 14 (58.3) |
| Crohn’s disease | 2 (8.3) |
| Indeterminate IBD | 1 (4.2) |
| No IBD | 7 (29.2) |
| IBD activity: Physician’s Global Assessment*, n (%) | |
| Normal | 15 (62.5) |
| Partial Mayo score | 4 (16.7) |
| Mild disease | 4 (16.7) |
| Moderate disease | 0 |
| Severe disease | 0 |
| Assessment not performed | 5 (20.8) |
| Received UDCA for at least 3 months before screening, n (%) | 7 (29.2) |
*
The partial Mayo score was used only for participants with IBD.
Abbreviation: BMI, body mass index.